Can a med spa in Kansas offer compounded semaglutide or tirzepatide?
Facility · part of The Practice Perimeter
Short answer
Only if a prescriber identifies a specialized medical need of an individual patient that an FDA-approved semaglutide or tirzepatide cannot fill; stock may be prepared ahead only on regularly observed prescribing, and the research limb bars sale or dispensing.
This is the compounded-semaglutide question answered inside the definition itself, and Kansas sets a test the drug’s own availability decides. Compounding is the combining of components into a compounded preparation "Compounding" means the combining of components into a compounded preparation under either of the following conditions: (A) As the result of a practitioner's prescription drug order or initiative based on the practitioner-patient-pharmacist relationship in the course of professional practice to meet the specialized medical need of an individual patient of the practitioner that cannot be filled by an FDA-approved drug Semaglutide and tirzepatide ARE available as FDA-approved drugs, so in Kansas a compounded version has to answer a specialized medical need of an identified patient that the approved product cannot meet — commercial preference or price is not that need.
K.S.A. § 65-1626(k)(1)(A) (compounding must meet a need an FDA-APPROVED DRUG CANNOT FILL) · verified Sep 6, 2026 · regulatory monitoring, not legal advice
Related Kansas rules
The definition's only other limb is not a commercial route. for the purpose of, or incidental to, research, teaching or chemical analysis, and not for sale or dispensing A clinic cannot reach compounded stock through the research limb, because that limb excludes sale and dispensing on its face.
K.S.A. § 65-1626(k)(1)(B) (the research limb is expressly NOT for sale or dispensing) · verified Sep 6, 2026
A 503B supplier is defined by its federal registration. "Outsourcing facility" means a facility at one geographic location or address that is engaged in the compounding of sterile drugs and has registered with the FDA as an outsourcing facility pursuant to 21 U.S.C. § 353b.
K.S.A. § 65-1626(vv) (definition of “Outsourcing facility”) · verified Sep 6, 2026
How other states answer this
- Alabama
- Alaska
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- Delaware
- District of Columbia
- Florida
- Georgia
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kentucky
- Louisiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montana
- Nebraska
- Nevada
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Vermont
- Virginia
- Washington
- West Virginia
- Wisconsin
- Wyoming
Related Kansas questions
- Is an exam required before a patient can be treated in Kansas?
- Can the pre-treatment exam be done by telehealth in Kansas?
Get Kansas changes as they publish
We scan the Kansas legislature and licensing boards daily, plus the FDA and the Federal Register. Free weekly Brief — what changed, in plain language, with the source.
Free · unsubscribe in one click · we never sell your address
← All Kansas rules and changes · MedSpaRadar is regulatory monitoring and reference: it summarizes public laws, regulations and agency actions and links each to its source. It is not legal, medical, or compliance advice, and using it creates no attorney-client relationship. A summary can lag its source or leave out detail, and monitoring itself can be interrupted — so an absence of alerts means nothing reached you, not that nothing happened. Read the cited source, check its effective date, and confirm any change to your operations or clinical practice with qualified health-law counsel and your medical director. Legislative data via LegiScan (CC BY 4.0).